Abstract
Recent studies have shown that overexpression of metastasis-associated in colon cancer 1 (MACC1) is significantly associated with adverse prognoses of patients with different kinds of cancer. However, the exact survival effect of MACC1 on epithelial ovarian cancer (EOC) patients has not yet been established. Thus, the objective of this study was to explore the prognostic role of MACC1 mRNA in EOC by using Kaplan-Meier (KM) plotter and ONCOMINE database. Our results indicated that MACC1 mRNA high expression was significantly associated with unfavorable overall survival (hazard ratio (HR) = 1.51 (95% confidence interval (CI): 1.21 – 1.88), P = 0.00025) and progression-free survival (HR = 1.53 (95% CI: 1.24 – 1.89), P = 5.8e-05) in EOC patients. We also found that the expression of MACC1 mRNA in EOC was 2.5 times higher than that in normal surface ovarian epithelium, which was statistically significant (P = 2.86e-7). Our results suggest that MACC1 expression might be a biomarker for poor prognosis in individual EOC patients.
| Original language | English |
|---|---|
| Article number | 9207153 |
| Journal | BioMed Research International |
| Volume | 2018 |
| DOIs | |
| Publication status | Published - 2018 Jan 1 |
Fingerprint
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Immunology and Microbiology(all)
Cite this
Prognostic characteristics of MACC1 expression in epithelial ovarian cancer. / Jeong, Hoiseon; Jung, Jiyoon; Oh, Hwa Eun; Choi, Jung-Woo; Lee, Eung Seok; Kim, Young Sik; Lee, Ju-Han.
In: BioMed Research International, Vol. 2018, 9207153, 01.01.2018.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Prognostic characteristics of MACC1 expression in epithelial ovarian cancer
AU - Jeong, Hoiseon
AU - Jung, Jiyoon
AU - Oh, Hwa Eun
AU - Choi, Jung-Woo
AU - Lee, Eung Seok
AU - Kim, Young Sik
AU - Lee, Ju-Han
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Recent studies have shown that overexpression of metastasis-associated in colon cancer 1 (MACC1) is significantly associated with adverse prognoses of patients with different kinds of cancer. However, the exact survival effect of MACC1 on epithelial ovarian cancer (EOC) patients has not yet been established. Thus, the objective of this study was to explore the prognostic role of MACC1 mRNA in EOC by using Kaplan-Meier (KM) plotter and ONCOMINE database. Our results indicated that MACC1 mRNA high expression was significantly associated with unfavorable overall survival (hazard ratio (HR) = 1.51 (95% confidence interval (CI): 1.21 – 1.88), P = 0.00025) and progression-free survival (HR = 1.53 (95% CI: 1.24 – 1.89), P = 5.8e-05) in EOC patients. We also found that the expression of MACC1 mRNA in EOC was 2.5 times higher than that in normal surface ovarian epithelium, which was statistically significant (P = 2.86e-7). Our results suggest that MACC1 expression might be a biomarker for poor prognosis in individual EOC patients.
AB - Recent studies have shown that overexpression of metastasis-associated in colon cancer 1 (MACC1) is significantly associated with adverse prognoses of patients with different kinds of cancer. However, the exact survival effect of MACC1 on epithelial ovarian cancer (EOC) patients has not yet been established. Thus, the objective of this study was to explore the prognostic role of MACC1 mRNA in EOC by using Kaplan-Meier (KM) plotter and ONCOMINE database. Our results indicated that MACC1 mRNA high expression was significantly associated with unfavorable overall survival (hazard ratio (HR) = 1.51 (95% confidence interval (CI): 1.21 – 1.88), P = 0.00025) and progression-free survival (HR = 1.53 (95% CI: 1.24 – 1.89), P = 5.8e-05) in EOC patients. We also found that the expression of MACC1 mRNA in EOC was 2.5 times higher than that in normal surface ovarian epithelium, which was statistically significant (P = 2.86e-7). Our results suggest that MACC1 expression might be a biomarker for poor prognosis in individual EOC patients.
UR - http://www.scopus.com/inward/record.url?scp=85062824514&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062824514&partnerID=8YFLogxK
U2 - 10.1155/2018/9207153
DO - 10.1155/2018/9207153
M3 - Article
C2 - 30515418
AN - SCOPUS:85062824514
VL - 2018
JO - BioMed Research International
JF - BioMed Research International
SN - 2314-6133
M1 - 9207153
ER -